Bladder Cancer Trial, Recruiting (NCT07234968)

Bladder Cancer Trial, Recruiting NCT07234968 Sponsor: Thomas Jefferson University Condition: Bladder Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07234968 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bladder Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are willing and able to sign a consent form agreeing to take part in the study
People who are able to follow all study procedures and commit to participating for the full duration of the study
People who are between 18 and 85 years old (male or female)
People who have been diagnosed with bladder cancer or another cancer in the pelvic area (such as colorectal, prostate, or gynecologic cancer) that requires surgical removal of the bladder, and who have chosen to have that surgery with a specific type of urinary diversion called an ileal conduit

Who may not be able to join:

People who have had radiation treatment to the pelvic area in the past, or who are currently receiving it
People who have a condition called retroperitoneal fibrosis (a build-up of scar tissue in the abdomen — confirm with trial site if unsure whether this applies)
People who had an untreated urinary tract infection (UTI) within the 30 days before the planned surgery
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mihir S Shah, MD, Thomas Jefferson University

Phone: 215-955-6961

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07234968

Sponsor: Thomas Jefferson University

Phase: Not Applicable

Status: Recruiting

Condition: Bladder Cancer

Trial contact: 215-955-6961

More information: https://clinicaltrials.gov/study/NCT07234968

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are willing and able to sign a consent form agreeing to take part in the study
People who are able to follow all study procedures and commit to participating for the full duration of the study
People who are between 18 and 85 years old (male or female)
People who have been diagnosed with bladder cancer or another cancer in the pelvic area (such as colorectal, prostate, or gynecologic cancer) that requires surgical removal of the bladder, and who have chosen to have that surgery with a specific type of urinary diversion called an ileal conduit

Who may not be able to join:

People who have had radiation treatment to the pelvic area in the past, or who are currently receiving it
People who have a condition called retroperitoneal fibrosis (a build-up of scar tissue in the abdomen — confirm with trial site if unsure whether this applies)
People who had an untreated urinary tract infection (UTI) within the 30 days before the planned surgery
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Thomas Jefferson University

Registry

ClinicalTrials.gov

Start date

23 December 2025

Est. completion

30 April 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of urinary tract infection (UTI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov